Outcome of Myeloablative Conditioning and Unrelated Donor Hematopoietic Cell Transplantation for Childhood Acute Lymphoblastic Leukemia in Third Remission
Eneida R. Nemecek(Oregon Health & Science University), Paul A. Carpenter(Fred Hutch Cancer Center), Kristin Ellis, Michael A. Pulsipher(Primary Children's Hospital), Margaret L. MacMillan(University of Minnesota Medical Center), Alexandra Cheerva(Kosair Children's Hospital), Haydar Frangoul(Children’s Hospital at TriStar Centennial), Stella M. Davies(Cincinnati Children's Hospital Medical Center), Mary Eapen(Medical College of Wisconsin), Ann E. Woolfrey(University of Washington), Christopher C. Dvorak(University of California, San Francisco), Adriana Seber(Support group for adolescents and children with cancer), Thomas G. Gross(Center for Global Health), Wensheng He(Medical College of Wisconsin), Michel Duval(Hôpital Robert-Debré), Parinda A. Mehta(Cincinnati Children's Hospital Medical Center), Rajinder S. Bajwa(Nationwide Children's Hospital), Nancy Bunin(University of Iowa), Ayad Ahmed Hussein(King Hussein Cancer Center), Mitchell S. Cairo(New York Medical College)
Cited by 15
Related Papers
Tisagenlecleucel in Children and Young Adults with B-Cell Lymphoblastic Leukemia
|New England Journal of Medicine|2018|5.7k
CRISPR-Cas9 Gene Editing for Sickle Cell Disease and β-Thalassemia
|New England Journal of Medicine|2020|1.8k
Guidelines for the Management of Pediatric and Adult Tumor Lysis Syndrome: An Evidence-Based Review
|Journal of Clinical Oncology|2008|794
Current Use of and Trends in Hematopoietic Cell Transplantation in the United States
|Transplantation and Cellular Therapy|2020|718
Genetic mechanisms of target antigen loss in CAR19 therapy of acute lymphoblastic leukemia
|Nature Medicine|2018|577